Skip to content

To evaluate the diagnostic ability of multi-method combined detection for invasive aspergillus infection in ICU

To evaluate the diagnostic ability of multi-method combined detection for invasive aspergillus infection in ICU

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100054337
Enrollment
Unknown
Registered
2021-12-14
Start date
2021-12-10
Completion date
Unknown
Last updated
2022-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Invasive Aspergillus infection

Interventions

Gold Standard:Traditional microbial detection methods (culture, microscopy, G test, GM test, etc.)
Index test:Aspergillus&#32
LFD&#32
combined&#32
with&#32

Sponsors

Shenzhen Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. The patients voluntarily participate in the research and sign the written informed consent; 2. Patients with pulmonary infection who are admitted to the ICU and need to carry out bronchoalveolar lavage according to the judgment of the clinician; 3. Have the following risk factors for Aspergillus infection: COPD, long-term steroid therapy, liver cirrhosis, influenza, diabetes, neutropenia, hematopoietic stem cell transplantation, organ transplantation, congenital and acquired immune deficiencies, chronic kidney disease, advanced age or other risk factors.

Exclusion criteria

Exclusion criteria: 1. Focus on people who have taken preventive medication for the prevention of Aspergillus infection and have not stopped taking the medication; 2. Diagnosed with chronic pulmonary aspergillosis; 3. Diagnosed with other species of pulmonary (such as Candida, Cryptococcus) fungal infection; 4. Pregnant patients; 5. Patients under the age of 14; 6. The test data is invalid due to the failure of sample extraction and other processing, and the laboratory diagnosis by multiple methods cannot be carried out according to the experimental requirements.

Design outcomes

Primary

MeasureTime frame
1,3-ß-D-glucan detection (G test);Galactomannan test (GM test);Aspergillus antigen immunochromatographic rapid test (AspLFD);Aspergillus nucleic acid multiplex qPCR detection;

Countries

China

Contacts

Public ContactMeng Xinke

Shenzhen Second People's Hospital

814313000@qq.com+86 13751017051

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026